| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Clinical efficacy of direct-acting antiviral therapy for recurrent hepatitis C virus infection after liver transplantation in patients with hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Mohamed Saleh Ismail, Manal Hassan, Saira Aijaz Khaderi, Wael Ahmed Yousry, Maha Mohsen Kamal El-Din, Mohamed Mohamed Bahaa El-Din, Osama Aboelfotoh El Sayed, Ahmed Omar Kaseb, John Alan Goss, Fasiha Kanwal and Prasun Kumar Jalal |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Ministry of Higher Education, Egypt |
JS-3787 |
|
| Corresponding Author |
Mohamed Saleh Ismail, MBChB, MSc, Doctor, Doctor, Research Fellow, Division of Gastroenterology, Baylor College of Medicine, One Baylor plaza, Houston, TX 77030, United States. mohamed.ismail@bcm.edu |
| Key Words |
Direct-acting antiviral; Liver transplant; Hepatocellular carcinoma; Recurrence; ; |
| Core Tip |
Our study is the first to find an association between direct-acting antiviral relapse and hepatocellular carcinoma (HCC) recurrence in patients with past history of HCC pre-transplant. Also, our study is the first to highlight high sustained virologic response in patients with past history of HCC after liver transplantation which is similar to patients without past history of HCC as we removed the tumor-harboring liver. |
| Publish Date |
2020-09-21 16:02 |
| Citation |
Ismail MS, Hassan M, Khaderi SA, Yousry WA, Kamal El-Din MM, Bahaa El-Din MM, El Sayed OA, Kaseb AO, Goss JA, Kanwal F, Jalal PK. Clinical efficacy of direct-acting antiviral therapy for recurrent hepatitis C virus infection after liver transplantation in patients with hepatocellular carcinoma. World J Hepatol 2020; 12(9): 628-640 |
| URL |
https://www.wjgnet.com/1948-5182/full/v12/i9/628.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v12.i9.628 |
